GraphWear Technologies
No Blood, No Pain.
- Headquarters
- San Francisco, California
- Employees
- 11–50
- Business Model
- B2C
- Website
- graphwear.co
- Last Round
- Series BOct 2021
- Rounds
- 3
About
GraphWear Technologies is developing an investigational needle-free, continuous glucose monitoring wearable that measures biometrics through nanotechnology on the skin surface without any needles or blood draws. The device is designed for real-time alerts and continuous monitoring of glucose and other health metrics. GraphWear has raised a Series B to advance its non-invasive disease management platform.
Summary
GraphWear Technologies is an Insurtech company based in San Francisco, United States. Its most recent funding was a Series B round in Oct 2021. Investors include Mayfield Fund, Bio Innovation Capital and Mission Bay Capital.
Tech & App Stack
3 technologies & apps tracked
Create a free account to track companies, build lists, and unlock premium data like the full tech & app stack.
Sign up to view funding chart
Create a free account to see funding visualizations and detailed round data.
Funding History
Oct 2021
Sign up to see all 3 rounds
Full funding history, per-round amounts, and investor participation.
Investors
Similar Companies
Global contract research organization providing comprehensive drug development and laboratory ser...
Global fertility clinics platform
Biopharmaceutical services company
Specialty pharmaceutical company
Biotech advancing cellular rejuvenation programming to restore cell health and reverse disease.
Global oncology biopharmaceutical company developing and commercializing cancer treatments, now r...